Search by category - Any -Regulated informationInside informationNon-regulated information Search by year - Any -2024202320222021202020192018201720162015 1 April 2021 Biocartis Announces Publication of 2020 Annual Report Regulated information 22 March 2021 Biocartis Launches Idylla™ GeneFusion Assay as Rapid Lab Workflow Solution for Gene Fusion Testing Non-regulated information 25 February 2021 BIOCARTIS ANNOUNCES 2020 RESULTS AND 2021 OUTLOOK Regulated information 18 February 2021 Biocartis Announces 2020 Full Year Results on 25 February 2021 Regulated information 2 February 2021 New US Studies Demonstrate Idylla™ Allows Rapid First Assessment of Most Common EGFR Mutations Preceding NGS Non-regulated information 11 January 2021 BIOCARTIS MEETS 2020 KEY OBJECTIVES Regulated information 17 December 2020 Disclosure of outstanding voting securities Regulated information 7 December 2020 Biocartis Announces the Conversion of EUR 15 million of its EUR 150 million 4% Convertible Bonds due 2024 Inside information Regulated information 24 November 2020 Disclosure of a transparency notification Regulated information 17 November 2020 Biocartis Announces Publication of Large Multi-Center Comparison Study with Idylla™ MSI Assay Showing Very Low Failure Rates and Excellent Concordance with Reference Methods Non-regulated information Pagination First page « First Previous page ‹‹ … Page 8 Page 9 Page 10 Page 11 Current page 12 Page 13 Page 14 Page 15 Page 16 … Next page ›› Last page Last »